-
-
Low intensity warfarin therapy effectively prevents recurrent venous thromboembolism, according to a recent study in the New England Journal of Medicine.
-
In patients with active lymphocytic myocarditis and persistent heart failure for greater than 6 months, those with circulating cardiac autoantibodies and no viral genomes detected on myocardial biopsy are the most likely to benefit from immunosuppressive therapy.
-
While the clinical benefit of oral N-acetylcysteine on reducing rates of contrast nephropathy for a given patient is unproven, it should be considered for all patients with abnormal renal function referred for elective coronary angiography.
-
-
Although fibrinolytic therapy was highly successful for thrombosis of prosthetic mechanical heart valves, a high complication rate limits its use to nonsurgical candidates.
-
Rheumatoid arthritis should be recognized as a marker of increased risk for myocardial infarction.
-
-
Recently, the Centers for Medicare and Medicaid Services proposed several changes to EMTALA that attempt to clarify hospital and physician duties. Undoubtedly, this new legislation will have an impact upon the care of emergency patients and the emergency physicians caring for them.
-
In the constantly shifting landscape of drug resistance, antibiotic options, and pharmacoeconomic considerations, urinary tract infection continues to be one of the most frequently diagnosed conditions in patients presenting to the emergency department.